Paper30825614
Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours.
Knight JC and 6 others. Nucl Med Biol, 2019. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours. Papers, record 30825614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30825614
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunoconjugates | Major topic |
| Indium Radioisotopes | Major topic |
| Positron-Emission Tomography | Major topic |
| Radioisotopes | Major topic |
| Tomography, Emission-Computed, Single-Photon | Major topic |
| Zirconium | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| Immunohistochemistry | |
| Isotope Labeling | |
| Mice | |
| Erb-b2 Receptor Tyrosine Kinases | |
| Tissue Distribution |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 16466 | Cancer Research UK | United Kingdom | PubMed | |
| 23970 | Cancer Research UK | United Kingdom | PubMed | |
| MR/P018661/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22434634 | Dual-isotope 111In/177Lu SPECT imaging as a tool in molecular imaging tracer design. | Contrast Media Mol Imaging | 2012 | https://conductscience.org/library/papers/22434634 | PubMed |
| 2 | 15648552 | Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan. | J Endocrinol Invest | 2004 | https://conductscience.org/library/papers/15648552 | PubMed |
| 3 | 16467105 | Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16467105 | PubMed |
| 4 | 26986633 | Scaling-down antibody radiolabeling reactions with zirconium-89. | Dalton Trans | 2016 | https://conductscience.org/library/papers/26986633 | PubMed |
| 5 | 28842811 | Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody. | Mol Imaging Biol | 2018 | https://conductscience.org/library/papers/28842811 | PubMed |
| 6 | 28036044 | Immuno-PET for Clinical Theranostic Approaches. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/28036044 | PubMed |
| 7 | 32262748 | Visualisation of dual radiolabelled poly(lactide-co-glycolide) nanoparticle degradation in vivo using energy-discriminant SPECT. | J Mater Chem B | 2015 | https://conductscience.org/library/papers/32262748 | PubMed |
| 8 | 6563945 | Specific localization of In-111-labeled monoclonal antibody versus 67-Ga-labeled immunoglobulin in mice bearing human breast carcinoma xenografts. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6563945 | PubMed |
| 9 | 28358075 | Cancer: Imaging with antibodies. | Nature | 2017 | https://conductscience.org/library/papers/28358075 | PubMed |
| 10 | 27151988 | Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT. | J Nucl Med | 2016 | https://conductscience.org/library/papers/27151988 | PubMed |
| 11 | 16862189 | Drug penetration in solid tumours. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16862189 | PubMed |
| 12 | 26573799 | An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. | Cancer Res | 2016 | https://conductscience.org/library/papers/26573799 | PubMed |
| 13 | 20441782 | The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. | Adv Drug Deliv Rev | 2011 | https://conductscience.org/library/papers/20441782 | PubMed |
| 14 | 16609026 | Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16609026 | PubMed |
| 15 | 21421727 | Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system. | J Nucl Med | 2011 | https://conductscience.org/library/papers/21421727 | PubMed |
| 16 | 25779566 | Antibody positron emission tomography imaging in anticancer drug development. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25779566 | PubMed |
| 17 | 26598545 | Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. | Ann Oncol | 2016 | https://conductscience.org/library/papers/26598545 | PubMed |
| 18 | 23708196 | A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. | J Nucl Med | 2013 | https://conductscience.org/library/papers/23708196 | PubMed |
| 19 | 18065843 | Quantitative simultaneous In-111/Tc-99m planar imaging in a long-bone infection phantom. | Phys Med Biol | 2007 | https://conductscience.org/library/papers/18065843 | PubMed |
| 20 | 19356571 | Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging. | JACC Cardiovasc Imaging | 2009 | https://conductscience.org/library/papers/19356571 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39493887 | Combining PET and Compton imaging with edge-on CZT detectors for enhanced diagnostic capabilities. | Adv Radiother Nucl Med | 2024 | https://conductscience.org/library/papers/39493887 | PubMed |
| 39196448 | Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation. | EJNMMI Res | 2024 | https://conductscience.org/library/papers/39196448 | PubMed |
| 38952401 | Comparison of Tumor Non-specific and PD-L1 Specific Imaging by Near-Infrared Fluorescence/Cerenkov Luminescence Dual-Modality In-situ Imaging. | Mol Imaging | 2024 | https://conductscience.org/library/papers/38952401 | PubMed |
| 37902935 | Influence of spill-over for 99mTc images and the effect of scatter correction for dual-isotope simultaneous acquisition with 99mTc and 18F using small-animal SPECT-PET/CT system. | Phys Eng Sci Med | 2024 | https://conductscience.org/library/papers/37902935 | PubMed |
| 37233321 | Intraoperative Gamma Cameras: A Review of Development in the Last Decade and Future Outlook. | J Imaging | 2023 | https://conductscience.org/library/papers/37233321 | PubMed |
| 36911362 | Hybrid PET/Compton-camera imaging: an imager for the next generation. | Eur Phys J Plus | 2023 | https://conductscience.org/library/papers/36911362 | PubMed |
| 35978576 | Immunohistochemistry of Immune Cells and Cells Bound to in vivo Administered Antibodies in Liver, Lung, Pancreas, and Colon of B6/lpr Mice. | Bio Protoc | 2022 | https://conductscience.org/library/papers/35978576 | PubMed |
| 35867034 | Synthesis and In Vivo Evaluation of a Site-specifically Labeled Radioimmunoconjugate for Dual-Modal (PET/NIRF) Imaging of MT1-MMP in Sarcomas. | Bioconjug Chem | 2022 | https://conductscience.org/library/papers/35867034 | PubMed |
| 34286423 | Examining the Feasibility of Quantifying Receptor Availability Using Cross-Modality Paired-Agent Imaging. | Mol Imaging Biol | 2022 | https://conductscience.org/library/papers/34286423 | PubMed |
| 33042280 | Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography. | Theranostics | 2020 | https://conductscience.org/library/papers/33042280 | PubMed |
| 32664521 | Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32664521 | PubMed |
| 31757844 | Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. | J Nucl Med | 2020 | https://conductscience.org/library/papers/31757844 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ERBB3 | 2065 | PubTator's text mining | https://conductscience.org/library/genes/2065 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30825614
GET https://conductscience.org/api/papers/v1/30825614/references?page=2